GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Hunan Jingfeng Pharmaceutical Co Ltd (SZSE:000908) » Definitions » Cash, Cash Equivalents, Marketable Securities

Hunan Jingfeng Pharmaceutical Co (SZSE:000908) Cash, Cash Equivalents, Marketable Securities : ¥0.0 Mil (As of Mar. 2024)


View and export this data going back to 1999. Start your Free Trial

What is Hunan Jingfeng Pharmaceutical Co Cash, Cash Equivalents, Marketable Securities?

Hunan Jingfeng Pharmaceutical Co's quarterly cash, cash equivalents, marketable securities declined from Sep. 2023 (¥174.65 Mil) to Dec. 2023 (¥13.17 Mil) but then stayed the same from Dec. 2023 (¥13.17 Mil) to Mar. 2024 (¥0.00 Mil).

Hunan Jingfeng Pharmaceutical Co's annual cash, cash equivalents, marketable securities increased from Dec. 2021 (¥172.18 Mil) to Dec. 2022 (¥181.39 Mil) but then declined from Dec. 2022 (¥181.39 Mil) to Dec. 2023 (¥13.17 Mil).


Hunan Jingfeng Pharmaceutical Co Cash, Cash Equivalents, Marketable Securities Historical Data

The historical data trend for Hunan Jingfeng Pharmaceutical Co's Cash, Cash Equivalents, Marketable Securities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hunan Jingfeng Pharmaceutical Co Cash, Cash Equivalents, Marketable Securities Chart

Hunan Jingfeng Pharmaceutical Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cash, Cash Equivalents, Marketable Securities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 405.48 164.20 172.18 181.39 13.17

Hunan Jingfeng Pharmaceutical Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cash, Cash Equivalents, Marketable Securities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 180.55 162.43 174.65 13.17 -

Hunan Jingfeng Pharmaceutical Co Cash, Cash Equivalents, Marketable Securities Calculation

Cash and cash equivalents are the most liquid assets on the balance sheet. Cash equivalents are assets that are readily convertible into cash, such as money market holdings, short-term government bonds or Treasury bills, marketable securities and commercial paper.

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price.


Hunan Jingfeng Pharmaceutical Co  (SZSE:000908) Cash, Cash Equivalents, Marketable Securities Explanation

Marketable securities are very liquid as they tend to have maturities of less than one year. Furthermore, the rate at which these securities can be bought or sold has little effect on their prices.

A high number means either:

1) The company has competitive advantage generating lots of cash

2) Just sold a business or bonds (not necessarily good)

A low stockpile of cash usually means poor to mediocre economics.

There are 3 ways to create large cash reserve.

1) Sell new bonds or equity to public

2) Sell business or asset

3) It has an ongoing business generating more cash than it burns (usually means durable competitive advantage)

When a company is suffering a short term problem, Buffett looks at cash or marketable securities to see whether it has the financial strength to ride it out.

Important: Lots of cash and marketable securities + little debt = good chance that the business will sail on through tough times.

Test to see what is creating cash by looking at past 7 yrs of balance sheets. This will reveal how the cash was created.


Hunan Jingfeng Pharmaceutical Co Cash, Cash Equivalents, Marketable Securities Related Terms

Thank you for viewing the detailed overview of Hunan Jingfeng Pharmaceutical Co's Cash, Cash Equivalents, Marketable Securities provided by GuruFocus.com. Please click on the following links to see related term pages.


Hunan Jingfeng Pharmaceutical Co (SZSE:000908) Business Description

Traded in Other Exchanges
N/A
Address
500 Zhangyang Road, Pudong New District, 30th Floor, China Resources Times Square, Shanghai, CHN
Hunan Jingfeng Pharmaceutical Co Ltd is engaged in the manufacturing of pharmaceutical products in China. The company offers Chemical medicine, Biological medicine, and Traditional Chinese medicine. Some of its products include Lemai Wan, Analgesic, Fuping Capsules, and Tongdi Capsules among others.
Executives
Zhou Shen Dong Supervisors
Ye Xiang Wu Directors, executives
Ma Xian Peng Executives
Cong Shu Fen Executives
Zhang Jun Guo Executives
Jian Wei Guang Directors, executives
Bi Yuan Secretary, Director
Ou Yang Yan Li Secretary, Director
Luo Li Director
Luo Bin Director
Li Tong Directors, executives
Wei Ze Chun Director
Tang Zhi Executives
Ou Yang Chun Bao Executives
Mao Hui Executives

Hunan Jingfeng Pharmaceutical Co (SZSE:000908) Headlines

No Headlines